Literature DB >> 35761001

Microfluidics for the Isolation and Detection of Circulating Tumor Cells.

Jessica Sierra-Agudelo1, Romen Rodriguez-Trujillo2,3, Josep Samitier1,4,5.   

Abstract

Nowadays, liquid biopsy represents one of the most promising techniques for early diagnosis, monitoring, and therapy screening of cancer. This novel methodology includes, among other techniques, the isolation, capture, and analysis of circulating tumor cells (CTCs). Nonetheless, the identification of CTC from whole blood is challenging due to their extremely low concentration (1-100 per ml of whole blood), and traditional methods result insufficient in terms of purity, recovery, throughput and/or viability of the processed sample. In this context, the development of microfluidic devices for detecting and isolating CTCs offers a wide range of new opportunities due to their excellent properties for cell manipulation and the advantages to integrate and bring different laboratory processes into the microscale improving the sensitivity, portability, reducing cost and time. This chapter explores current and recent microfluidic approaches that have been developed for the analysis and detection of CTCs, which involve cell capture methods based on affinity binding and label-free methods and detection based on electrical, chemical, and optical sensors. All the exposed technologies seek to overcome the limitations of commercial systems for the analysis and isolation of CTCs, as well as to provide extended analysis that will allow the development of novel and more efficient diagnostic tools.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Cancer detection; Cancer diagnosis; Circulating tumor cells; Liquid biopsy; Microfluidics

Mesh:

Year:  2022        PMID: 35761001     DOI: 10.1007/978-3-031-04039-9_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  71 in total

Review 1.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

2.  Urinary cell-free DNA as a prognostic marker for KRAS-positive advanced-stage NSCLC.

Authors:  F Xie; P Li; J Gong; H Tan; J Ma
Journal:  Clin Transl Oncol       Date:  2017-09-27       Impact factor: 3.405

Review 3.  Applications of liquid biopsies for cancer.

Authors:  Austin K Mattox; Chetan Bettegowda; Shibin Zhou; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

Review 4.  Circulating tumor DNA as a liquid biopsy for cancer.

Authors:  Ellen Heitzer; Peter Ulz; Jochen B Geigl
Journal:  Clin Chem       Date:  2014-11-11       Impact factor: 8.327

5.  Shear stress promotes anoikis resistance of cancer cells via caveolin-1-dependent extrinsic and intrinsic apoptotic pathways.

Authors:  Shun Li; Yu Chen; Yuehui Zhang; Xiaomin Jiang; Ying Jiang; Xiang Qin; Hong Yang; Chunhui Wu; Yiyao Liu
Journal:  J Cell Physiol       Date:  2018-08-31       Impact factor: 6.384

Review 6.  Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring.

Authors:  Ivana Martins; Ilda Patrícia Ribeiro; Joana Jorge; Ana Cristina Gonçalves; Ana Bela Sarmento-Ribeiro; Joana Barbosa Melo; Isabel Marques Carreira
Journal:  Genes (Basel)       Date:  2021-02-27       Impact factor: 4.096

7.  Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

Authors:  Bahriye Aktas; Mitra Tewes; Tanja Fehm; Siegfried Hauch; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Breast Cancer Res       Date:  2009-07-09       Impact factor: 6.466

Review 8.  Cancer metastases: challenges and opportunities.

Authors:  Xiangming Guan
Journal:  Acta Pharm Sin B       Date:  2015-09-08       Impact factor: 11.413

Review 9.  Refining Cancer Management Using Integrated Liquid Biopsy.

Authors:  Juhui Qiu; Jianxiong Xu; Kang Zhang; Wei Gu; Liming Nie; Guixue Wang; Yang Luo
Journal:  Theranostics       Date:  2020-01-16       Impact factor: 11.556

View more
  1 in total

Review 1.  Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.

Authors:  Maria Pallozzi; Natalia Di Tommaso; Valeria Maccauro; Francesco Santopaolo; Antonio Gasbarrini; Francesca Romana Ponziani; Maurizio Pompili
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.